Enhancing Surgical Visualization: ZEISS Receives NMPA Approval for Ophthalmic Microscopes
In a significant advancement for the field of ophthalmic surgery, ZEISS Medical Technology has received approval from China's National Medical Products Administration (NMPA) for its state-of-the-art ARTEVO 750 and ARTEVO 850 microscopes. This groundbreaking recognition underscores ZEISS's commitment to enhancing surgical precision and safety in ophthalmology, thereby improving patient outcomes in the region.
The ARTEVO 750 and 850 models are designed to support an end-to-end workflow for ophthalmic surgeons, delivering exceptional optical and digital visualization for both anterior and posterior segments of the eye. With improved hardware and software upgrades, these surgical microscopes are set to play a vital role in a variety of procedures, including cataract surgeries, vitreoretinal operations, corneal transplantation, and minimally invasive glaucoma surgery (MIGS).
Martin Fischer, President and CEO of ZEISS Greater China, expressed his enthusiasm about the launch, stating, "The introduction of ZEISS ARTEVO 750 and 850 microscopes powerfully demonstrates our commitment to ophthalmologists in China. We will leverage the power of innovation to contribute to the advancement of eye health in China and better serve Chinese surgeons and their patients."
The ARTEVO 750, in particular, boasts a combination of advanced technology with ZEISS’s established optical expertise. It allows surgeons to finely adjust their visual perspective during various types of surgeries. Enhanced features like RGB illumination and intelligent intraoperative optical coherence tomography (OCT) improve usability and workflow efficiency. Professor Chen Jili from Shanghai Jing'an District Shibei Hospital noted, "The enhanced optical resolution of the ARTEVO 750 enables us to elevate our capabilities in performing delicate ophthalmic surgeries."
On the other hand, the ARTEVO 850 is a pioneering 3D-enabled digital microscope that redefines ophthalmic visualization. This model integrates the benefits of digital imaging with customizable features, excellent user interface, and sound integration into a holistic medical ecosystem. It is equipped with a Digital Color Assistant (DCA) that enriches the surgical image, accentuating important anatomical details. Notably, it provides an intelligence-based Smart Depth of Field function, optimizing depth of field by up to 60% compared to previous models, further enhancing surgical precision.
"The resolution of the ARTEVO 850 is truly excellent, and the clear visibility and reduced fatigue during surgery make the experience very pleasant," comments Professor Xu Gezhi from the EENT Hospital of Fudan University. Such professional endorsements highlight the significant impact these tools can have on improving the surgical landscape in China.
The introduction of the next generation ZEISS ophthalmic microscopes marks a paradigm shift in surgical practice, merging superior optics with state-of-the-art technology. The ARTEVO 850 will be on display during the upcoming 41st Asia-Pacific Academy of Ophthalmology (APAO) conference, taking place in Hong Kong from February 5-8, 2026, signaling not just a technological leap but also ZEISS’s unwavering commitment to supporting healthcare professionals in their quest for excellence. For further details on ZEISS ophthalmic surgical microscopes, interested parties are encouraged to visit their official website.
Carl Zeiss Meditec AG is known for its pioneering contributions to medical technology and continues to generate innovative solutions aimed at improving the quality of life for patients. The company represents a blend of expert craftsmanship and cutting-edge technology, ensuring that healthcare providers are equipped with tools that enhance precision and overall medical care. As the company looks ahead, the enthusiasm surrounding these new approvals is indicative of a promising future for ophthalmic procedures and patient care in China and beyond.
The ARTEVO 750 and 850 models are designed to support an end-to-end workflow for ophthalmic surgeons, delivering exceptional optical and digital visualization for both anterior and posterior segments of the eye. With improved hardware and software upgrades, these surgical microscopes are set to play a vital role in a variety of procedures, including cataract surgeries, vitreoretinal operations, corneal transplantation, and minimally invasive glaucoma surgery (MIGS).
Martin Fischer, President and CEO of ZEISS Greater China, expressed his enthusiasm about the launch, stating, "The introduction of ZEISS ARTEVO 750 and 850 microscopes powerfully demonstrates our commitment to ophthalmologists in China. We will leverage the power of innovation to contribute to the advancement of eye health in China and better serve Chinese surgeons and their patients."
The ARTEVO 750, in particular, boasts a combination of advanced technology with ZEISS’s established optical expertise. It allows surgeons to finely adjust their visual perspective during various types of surgeries. Enhanced features like RGB illumination and intelligent intraoperative optical coherence tomography (OCT) improve usability and workflow efficiency. Professor Chen Jili from Shanghai Jing'an District Shibei Hospital noted, "The enhanced optical resolution of the ARTEVO 750 enables us to elevate our capabilities in performing delicate ophthalmic surgeries."
On the other hand, the ARTEVO 850 is a pioneering 3D-enabled digital microscope that redefines ophthalmic visualization. This model integrates the benefits of digital imaging with customizable features, excellent user interface, and sound integration into a holistic medical ecosystem. It is equipped with a Digital Color Assistant (DCA) that enriches the surgical image, accentuating important anatomical details. Notably, it provides an intelligence-based Smart Depth of Field function, optimizing depth of field by up to 60% compared to previous models, further enhancing surgical precision.
"The resolution of the ARTEVO 850 is truly excellent, and the clear visibility and reduced fatigue during surgery make the experience very pleasant," comments Professor Xu Gezhi from the EENT Hospital of Fudan University. Such professional endorsements highlight the significant impact these tools can have on improving the surgical landscape in China.
The introduction of the next generation ZEISS ophthalmic microscopes marks a paradigm shift in surgical practice, merging superior optics with state-of-the-art technology. The ARTEVO 850 will be on display during the upcoming 41st Asia-Pacific Academy of Ophthalmology (APAO) conference, taking place in Hong Kong from February 5-8, 2026, signaling not just a technological leap but also ZEISS’s unwavering commitment to supporting healthcare professionals in their quest for excellence. For further details on ZEISS ophthalmic surgical microscopes, interested parties are encouraged to visit their official website.
Carl Zeiss Meditec AG is known for its pioneering contributions to medical technology and continues to generate innovative solutions aimed at improving the quality of life for patients. The company represents a blend of expert craftsmanship and cutting-edge technology, ensuring that healthcare providers are equipped with tools that enhance precision and overall medical care. As the company looks ahead, the enthusiasm surrounding these new approvals is indicative of a promising future for ophthalmic procedures and patient care in China and beyond.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.